SG Americas Securities, LLC

Broker-Dealer

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1313360 NEW YORK, NY

Position in ORIC

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$564,123

+$360,225 QoQ

Shares Held

52,089

+223.7% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#90

of 179 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. ORIC ranks #97 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$564,123	52,089	+223.7%	Shares	Sole	2026-08-07
2026-03-31	$203,898	16,093	-60.8%	Shares	Sole	2026-04-16
2025-12-31	$335,510	41,016	+127.6%	Shares	Sole	2026-01-09
2025-09-30	$216,276	18,023	-9.5%	Shares	Sole	2025-10-23
2025-03-31	$111,125	19,915	-70.0%	Shares	Sole	2025-04-15
2024-12-31	$535,557	66,364	-4.7%	Shares	Sole	2025-01-17
2024-09-30	$713,605	69,620	+200.7%	Shares	Sole	2024-10-03
2023-06-30	$179,644	23,150	+69.6%	Shares	Sole	2023-07-10
2021-12-31	$200,655	13,650	-45.9%	Shares	Sole	2022-02-07
2021-09-30	$527,663	25,235	+343.1%	Shares	Sole	2021-11-01
2021-03-31	$139,527	5,695	-93.8%	Shares	Sole	2021-05-13
2020-09-30	$2,300,844	91,997	+309.3%	Shares	Sole	2020-11-09
2020-06-30	$758,149	22,477	—	Shares	Sole	2020-07-20
No filing history on record for this holder in this stock.